Anti-DHRS3 monoclonal antibody

Pre-made anti-DHRS3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to DHRS3/DHRS3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0690-Ab-1/ GM-Tg-hg-IP0690-Ab-2Anti-Human DHRS3 monoclonal antibodyHuman
GM-Tg-rg-IP0690-Ab-1/ GM-Tg-rg-IP0690-Ab-2Anti-Rat DHRS3 monoclonal antibodyRat
GM-Tg-mg-IP0690-Ab-1/ GM-Tg-mg-IP0690-Ab-2Anti-Mouse DHRS3 monoclonal antibodyMouse
GM-Tg-cynog-IP0690-Ab-1/ GM-Tg-cynog-IP0690-Ab-2Anti-Cynomolgus/ Rhesus macaque DHRS3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0690-Ab-1/ GM-Tg-felg-IP0690-Ab-2Anti-Feline DHRS3 monoclonal antibodyFeline
GM-Tg-cang-IP0690-Ab-1/ GM-Tg-cang-IP0690-Ab-2Anti-Canine DHRS3 monoclonal antibodyCanine
GM-Tg-bovg-IP0690-Ab-1/ GM-Tg-bovg-IP0690-Ab-2Anti-Bovine DHRS3 monoclonal antibodyBovine
GM-Tg-equg-IP0690-Ab-1/ GM-Tg-equg-IP0690-Ab-2Anti-Equine DHRS3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0690-Ab-1/ GM-Tg-hg-IP0690-Ab-2; GM-Tg-rg-IP0690-Ab-1/ GM-Tg-rg-IP0690-Ab-2;
GM-Tg-mg-IP0690-Ab-1/ GM-Tg-mg-IP0690-Ab-2; GM-Tg-cynog-IP0690-Ab-1/ GM-Tg-cynog-IP0690-Ab-2;
GM-Tg-felg-IP0690-Ab-1/ GM-Tg-felg-IP0690-Ab-2; GM-Tg-cang-IP0690-Ab-1/ GM-Tg-cang-IP0690-Ab-2;
GM-Tg-bovg-IP0690-Ab-1/ GM-Tg-bovg-IP0690-Ab-2; GM-Tg-equg-IP0690-Ab-1/ GM-Tg-equg-IP0690-Ab-2
Products NameAnti-DHRS3 monoclonal antibody
Formatmab
Target NameDHRS3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-DHRS3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0690-Ag-1Recombinant multi-species DHRS3/ DD83.1/ RDH17 protein
    ORF Viral VectorpGMLP002499human DHRS3 Lentivirus plasmid
    ORF Viral VectorvGMLP002499human DHRS3 Lentivirus particle
    ORF Viral VectorpGMLPm002595mouse Dhrs3 Lentivirus plasmid
    ORF Viral VectorvGMLPm002595mouse Dhrs3 Lentivirus particle


    Target information

    Target IDGM-IP0690
    Target NameDHRS3
    Gene ID9249,20148,313689,715548,487436,101080307,281482,100055537
    Gene Symbol and SynonymsCNALPTC1,DD83.1,DHRS3,RDH17,retSDR1,Rsdr1,SDR1,SDR16C1
    Uniprot AccessionO75911,O77769
    Uniprot Entry NameDHRS3_HUMAN,DHRS3_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000162496
    Target ClassificationN/A

    The target: DHRS3, gene name: DHRS3, also named as DD83.1, RDH17, Rsdr1, SDR1, SDR16C1, retSDR1. Short-chain dehydrogenases/reductases (SDRs), such as DHRS3, catalyze the oxidation/reduction of a wide range of substrates, including retinoids and steroids (Haeseleer and Palczewski, 2000 [PubMed 10800688]).[supplied by OMIM, Jun 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.